Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00026403 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00006467 | Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 |
| NCT02382263 | Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer(FRAGANCE) | completed | Phase 1 / Phase 2 | 224 | PH Research, S.L.OTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00696696 | Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT01473303 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jun 28, 2016 | clinicaltrials |
| NCT00869258 | Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar | completed | Phase 2 | 32 | Columbia UniversityOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00674973 | A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 207 | Hoffmann-La RocheINDUSTRY | 19 | Jun 17, 2016 | clinicaltrials |
| NCT00871169 | Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 61 | New Mexico Cancer Research AllianceOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT01416662 | Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery | completed | Phase 2 | 120 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | May 30, 2016 | clinicaltrials |
| NCT02575508 | Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT00766636 | Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT02468076 | Radiofrequency Ablation for Biliopancreatic Malignancy(IGNITE-1) | completed | Phase 2 | 18 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT01395017 | Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer(LAPC) | completed | Phase 2 | 202 | Otsuka Pharmaceutical Development & Commercialization, Inc.INDUSTRY | 15 | Apr 8, 2016 | clinicaltrials |
| NCT00383149 | A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer | completed | Phase 2 | 58 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01658943 | Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy(S1115) | completed | Phase 2 | 137 | National Cancer Institute (NCI)NIH | 1 | Mar 9, 2016 | clinicaltrials |
| NCT00587964 | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT01509911 | A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment | unknown | Phase 2 | 99 | Tiltan Pharma Ltd.INDUSTRY | 2 | Feb 5, 2016 | clinicaltrials |
| NCT00100815 | Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer | completed | Phase 2 | 50 | Roswell Park Cancer InstituteOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT02634502 | Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT02133079 | Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 20 | Cure&Sure Biotech Co., LTDINDUSTRY | 1 | Dec 11, 2015 | clinicaltrials |
| NCT00864513 | Study of Pemetrexed for Second-Line Pancreas Cancer | terminated | Phase 2 | 17 | Georgetown UniversityOTHER | 1 | Dec 8, 2015 | clinicaltrials |
| NCT00456599 | Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer | completed | Phase 2 | 71 | University of Michigan Rogel Cancer CenterOTHER | 2 | Dec 3, 2015 | clinicaltrials |
| NCT00005832 | S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 58 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01693276 | Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 3 | Olugbenga OlowokureOTHER | 1 | Oct 26, 2015 | clinicaltrials |
| NCT01042028 | A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 39 | Per PfeifferOTHER | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00461708 | A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival | completed | Phase 2 | 153 | Hoffmann-La RocheINDUSTRY | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00561990 | Nimotuzumab in Adults With Pancreatic Cancer | completed | Phase 2 / Phase 3 | 188 | Oncoscience AGINDUSTRY | 1 | Oct 15, 2015 | clinicaltrials |
| NCT01454180 | Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets | completed | Phase 2 | 31 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00227773 | Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 8, 2015 | clinicaltrials |
| NCT01882946 | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Northwest BiotherapeuticsINDUSTRY | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00544908 | Dasatinib in Treating Patients With Stage IV Pancreatic Cancer | terminated | Phase 2 | 7 | City of Hope Medical CenterOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT00417976 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | completed | Phase 2 | 42 | Tony Bekaii-SaabOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT01598584 | Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT00902291 | A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer | completed | Phase 2 | 205 | Astellas Pharma IncINDUSTRY | 5 | Sep 14, 2015 | clinicaltrials |
| NCT00593866 | Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer | completed | Phase 1 / Phase 2 | 50 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 11, 2015 | clinicaltrials |
| NCT00570713 | An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer | completed | Phase 2 | 155 | MorphotekINDUSTRY | 5 | Sep 9, 2015 | clinicaltrials |
| NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | terminated | Phase 2 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT00053924 | Perifosine in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | — | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00733850 | Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer | completed | Phase 2 | 85 | KangLaiTe USAINDUSTRY | 1 | Jun 19, 2015 | clinicaltrials |
| NCT01298011 | Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer | completed | Phase 2 | 25 | Pancreatic Cancer Research TeamOTHER | 1 | Jun 17, 2015 | clinicaltrials |
| NCT01080248 | Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer | terminated | Phase 2 | 2 | Washington University School of MedicineOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT00660699 | A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | completed | Phase 2 | 50 | Washington University School of MedicineOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT00743379 | Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 71 | Threshold PharmaceuticalsINDUSTRY | 1 | May 7, 2015 | clinicaltrials |
| NCT00474812 | Dasatinib in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00253526 | Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 28, 2015 | clinicaltrials |
| NCT00238199 | Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | completed | Phase 2 | 25 | OHSU Knight Cancer InstituteOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT01167738 | Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer(PACT-17) | terminated | Phase 2 | 60 | IRCCS San RaffaeleOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT01587534 | Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) | completed | Phase 2 | 67 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00998322 | A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma | completed | Phase 2 | 34 | Oncolytics BiotechINDUSTRY | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00300950 | Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer | completed | Phase 2 | 176 | GlobeImmuneINDUSTRY | 2 | Apr 6, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jul 14, 2016source: clinicaltrials